Literature DB >> 25376411

Assessing risk and improving travel vaccine programs for business travelers.

William B Bunn.   

Abstract

Mesh：

Year:  2014        PMID： 25376411     DOI： 10.1097/JOM.0000000000000318

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN： 1076-2752            Impact factor:   2.162


× No keyword cloud information.
  3 in total

1.  Business travel-associated illness: a GeoSentinel analysis.

Authors:  Lin H Chen; Karin Leder; Kira A Barbre; Patricia Schlagenhauf; Michael Libman; Jay Keystone; Marc Mendelson; Philippe Gautret; Eli Schwartz; Marc Shaw; Sue MacDonald; Anne McCarthy; Bradley A Connor; Douglas H Esposito; Davidson Hamer; Mary E Wilson
Journal:  J Travel Med       Date:  2018-01-01       Impact factor: 8.490

2.  If I told you that there is no need for yellow fever vaccine booster would you still come to the travel clinic?: a cross-sectional study.

Authors:  Iolanda Alves; Rosa Teodósio; Filomena Pereira
Journal:  Trop Dis Travel Med Vaccines       Date:  2021-03-12

Review 3.  The changing epidemiology of Japanese encephalitis and New data: the implications for New recommendations for Japanese encephalitis vaccine.

Authors:  Bradley Connor; William B Bunn
Journal:  Trop Dis Travel Med Vaccines       Date:  2017-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.